Development of Serine Modification-based Kidney-targeted Drug Delivery System
-
- Katsumi Hidemasa
- Department of Biopharmaceutics, Kyoto Pharmaceutical University
-
- Morishita Masaki
- Department of Biopharmaceutics, Kyoto Pharmaceutical University
-
- Yamamoto Akira
- Department of Biopharmaceutics, Kyoto Pharmaceutical University
Bibliographic Information
- Other Title
-
- セリン修飾を用いた腎臓ターゲティング型ドラッグデリバリーシステムの開発
Abstract
<p>Kidney-targeted drug delivery is vital in treating kidney diseases by improving therapeutic efficacy and safety. However, targeting drugs to the kidney is challenging, as drug nano-carriers are usually trapped by the reticuloendothelial system in the liver and spleen. Recently, we reported that serine-modified polyamidoamine (Ser-PAMAM) dendrimer functions as a highly potent kidney-targeting drug carrier. Further, we demonstrated that Ser-PAMAM predominantly accumulated in the kidney, especially in proximal tubules, a pattern associated with the pathogenesis of chronic kidney diseases and renal carcinoma cells. Furthermore, captopril was successfully targeted to the kidney using Ser-PAMAM, and cysteine- or S-nitrosothiol (source of nitric oxide)-loaded Ser-PAMAM effectively suppressed the occurrence of renal injury following renal ischemia/reperfusion. In this review, we summarized recent challenges in developing a kidney-targeted drug delivery system and discussed the utility of our serine modification-based improvements to this system for the efficient treatment of kidney diseases.</p>
Journal
-
- YAKUGAKU ZASSHI
-
YAKUGAKU ZASSHI 143 (2), 121-126, 2023-02-01
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390013485543039488
-
- ISSN
- 13475231
- 00316903
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
-
- Abstract License Flag
- Disallowed